AMAG (AMAG) Price Target Lowered to $30 at Summer Street, Stock Remains Buy
Tweet Send to a Friend
Summer Street maintained a Buy rating on AMAG Pharmaceuticals (NASDAQ: AMAG) and lowered its price target to $30.00 (from $43.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
